Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|119|16|3020-3026

ISSN: 0008-543x

Source: CANCER, Vol.119, Iss.16, 2013-08, pp. : 3020-3026

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract